BEACON THERAPEUTICS LIMITED

Company number 14426488

Date	Type	Description	View / Download
30 Oct 2024	CS01	Confirmation statement made on 17 October 2024 with updates	(4 pages)
16 Oct 2024	AA	Full accounts made up to 31 December 2023	(31 pages)
02 Oct 2024	AP01	Appointment of Mr Lance Baldo as a director on 27 September 2024	(2 pages)
02 Oct 2024	TM01	Termination of appointment of David Andrew Fellows as a director on 27 September 2024	(1 page)
14 Jun 2024	SH01	Statement of capital following an allotment of shares on 11 June 2024 GBP 677.18669	(3 pages)
23 Jan 2024	AP01	Appointment of Mr Benjamin Thomas Rigby as a director on 17 January 2024	(2 pages)
23 Jan 2024	TM01	Termination of appointment of Christopher John Hollowood as a director on 18 January 2024	(1 page)
23 Jan 2024	TM01	Termination of appointment of Elisa Michela Petris as a director on 23 January 2024	(1 page)
20 Dec 2023	SH01	Statement of capital following an allotment of shares on 18 December 2023 GBP 677.17669	(3 pages)
17 Oct 2023	CS01	Confirmation statement made on 17 October 2023 with updates	(4 pages)
08 Aug 2023	SH01	Statement of capital following an allotment of shares on 3 August 2023 GBP 677.16669	(3 pages)
02 Aug 2023	PSC05	Change of details for Spl123 Limited as a person with significant control on 1 June 2023	(2 pages)
10 Jun 2023	MA	Memorandum and Articles of Association	(26 pages)
10 Jun 2023	RESOLUTIONS	Resolutions RES13 ‐ Change of name 24/05/2023 RES01 ‐ Resolution of adoption of Articles of Association	(2 pages)
05 Jun 2023	AD01	Registered office address changed from 8 Bloomsbury Street London WC1B 3SR England to Rolling Stock Yard 188 York Way London N7 9AS on 5 June 2023	(1 page)
01 Jun 2023	CERTNM	Company name changed alliance holdco LIMITED\certificate issued on 01/06/23 NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2023-05-24	(3 pages)
11 May 2023	PSC02	Notification of Spl123 Limited as a person with significant control on 6 March 2023	(2 pages)
11 May 2023	PSC09	Withdrawal of a person with significant control statement on 11 May 2023	(2 pages)
31 Mar 2023	AA01	Current accounting period extended from 31 October 2023 to 31 December 2023	(1 page)
15 Mar 2023	SH01	Statement of capital following an allotment of shares on 14 March 2023 GBP 677.15669	(3 pages)
08 Mar 2023	SH01	Statement of capital following an allotment of shares on 6 March 2023 GBP 566.11802	(3 pages)
15 Feb 2023	AP01	Appointment of Mr David Andrew Fellows as a director on 1 February 2023	(2 pages)
08 Jan 2023	SH02	Sub-division of shares on 23 December 2022	(6 pages)
24 Dec 2022	SH01	Statement of capital following an allotment of shares on 23 December 2022 GBP 408.33568	(3 pages)
18 Oct 2022	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted Statement of capital on 2022-10-18 GBP 1	(9 pages)